Schobel Alexander Mark
Insider CIK 1406836 · AQST SVP,Chief Innov/Tech Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AQST Aquestive Therapeutics, In | S Sale | 2024-03-15 | 2024-03-19 | 50,000 | $6.00 | $300.0K | 984,476 | SEC↗ |
| AQST Aquestive Therapeutics, In | F Tax w/h | 2024-03-09 | 2024-10-02 | 9,645 | $4.88 | $47.1K | 980,726 | SEC↗ |
| AQST Aquestive Therapeutics, In | F Tax w/h | 2024-03-09 | 2024-03-12 | 5,895 | $4.88 | $28.8K | 1,034,476 | SEC↗ |
| AQST Aquestive Therapeutics, In | S Sale | 2024-03-08 | 2024-03-12 | 25,000 | $5.19 | $129.8K | 1,040,371 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2024-03-07 | 2024-03-11 | 41,250 | — | $0 | 41,250 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award | 2024-03-07 | 2024-03-11 | 82,500 | — | $0 | 1,065,371 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2023-08-09 | 2023-08-09 | 50,000 | — | $0 | 50,000 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2023-05-05 | 2023-05-05 | 50,000 | — | $0 | 50,000 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award | 2023-03-09 | 2023-03-09 | 100,000 | — | $0 | 982,871 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2022-11-04 | 2022-11-08 | 40,000 | — | $0 | 40,000 | SEC↗ |
| AQST Aquestive Therapeutics, In | P Buy deriv | 2022-06-08 | 2022-06-10 | 45,871 | $0.13 | $6.0K | 45,871 | SEC↗ |
| AQST Aquestive Therapeutics, In | P Buy | 2022-06-08 | 2022-06-10 | 45,871 | $0.96 | $44.0K | 882,871 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2022-03-10 | 2022-03-14 | 75,000 | — | $0 | 75,000 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2021-03-11 | 2021-03-15 | 70,000 | — | $0 | 70,000 | SEC↗ |
| AQST Aquestive Therapeutics, In | S Sale | 2021-02-10 | 2021-02-10 | 23,460 | $6.75 | $158.4K | 837,000 | SEC↗ |
| AQST Aquestive Therapeutics, In | S Sale | 2021-02-09 | 2021-02-10 | 11,540 | $6.75 | $77.9K | 860,460 | SEC↗ |
| AQST Aquestive Therapeutics, In | S Sale | 2021-02-08 | 2021-02-09 | 40,792 | $6.50 | $265.1K | 872,000 | SEC↗ |
| AQST Aquestive Therapeutics, In | M Exercise deriv | 2020-06-30 | 2020-07-02 | 333 | — | $0 | 0 | SEC↗ |
| AQST Aquestive Therapeutics, In | F Tax w/h | 2020-06-30 | 2020-07-02 | 94 | $4.86 | $457 | 912,792 | SEC↗ |
| AQST Aquestive Therapeutics, In | M Exercise | 2020-06-30 | 2020-07-02 | 333 | — | $0 | 912,886 | SEC↗ |
| AQST Aquestive Therapeutics, In | M Exercise deriv | 2020-05-31 | 2020-06-02 | 14,572 | — | $0 | 0 | SEC↗ |
| AQST Aquestive Therapeutics, In | M Exercise | 2020-05-31 | 2020-06-02 | 14,572 | — | $0 | 916,685 | SEC↗ |
| AQST Aquestive Therapeutics, In | F Tax w/h | 2020-05-31 | 2020-06-02 | 4,132 | $4.87 | $20.1K | 912,553 | SEC↗ |
| AQST Aquestive Therapeutics, In | S Sale | 2020-05-08 | 2020-05-11 | 40,000 | $5.00 | $200.0K | 902,113 | SEC↗ |
| AQST Aquestive Therapeutics, In | S Sale | 2020-04-29 | 2020-05-01 | 40,000 | $4.50 | $180.0K | 1,022,113 | SEC↗ |
| AQST Aquestive Therapeutics, In | S Sale | 2020-04-27 | 2020-05-04 | 40,000 | $4.00 | $160.0K | 942,113 | SEC↗ |
| AQST Aquestive Therapeutics, In | S Sale | 2020-04-14 | 2020-05-04 | 40,000 | $3.70 | $148.0K | 982,113 | SEC↗ |
| AQST Aquestive Therapeutics, In | M Exercise deriv | 2020-03-31 | 2020-04-02 | 329 | — | $0 | 333 | SEC↗ |
| AQST Aquestive Therapeutics, In | M Exercise | 2020-03-31 | 2020-04-02 | 329 | — | $0 | 1,062,210 | SEC↗ |
| AQST Aquestive Therapeutics, In | F Tax w/h | 2020-03-31 | 2020-04-02 | 97 | $2.19 | $212 | 1,062,113 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2020-03-16 | 2020-03-18 | 70,000 | — | $0 | 70,000 | SEC↗ |
| AQST Aquestive Therapeutics, In | M Exercise deriv | 2020-02-29 | 2020-03-03 | 14,572 | — | $0 | 14,572 | SEC↗ |
| AQST Aquestive Therapeutics, In | M Exercise | 2020-02-29 | 2020-03-03 | 14,572 | — | $0 | 1,066,947 | SEC↗ |
| AQST Aquestive Therapeutics, In | F Tax w/h | 2020-02-29 | 2020-03-03 | 5,066 | $3.73 | $18.9K | 1,061,881 | SEC↗ |
| AQST Aquestive Therapeutics, In | M Exercise deriv | 2019-12-31 | 2020-01-02 | 329 | — | $0 | 662 | SEC↗ |
| AQST Aquestive Therapeutics, In | M Exercise | 2019-12-31 | 2020-01-02 | 329 | — | $0 | 1,044,494 | SEC↗ |
| AQST Aquestive Therapeutics, In | F Tax w/h | 2019-12-31 | 2020-01-02 | 329 | $5.82 | $1.9K | 1,044,165 | SEC↗ |
| AQST Aquestive Therapeutics, In | F Tax w/h | 2019-12-31 | 2020-02-26 | 147 | $5.82 | $856 | 1,052,375 | SEC↗ |
| AQST Aquestive Therapeutics, In | F Tax w/h | 2019-11-30 | 2020-02-26 | 6,544 | $7.79 | $51.0K | 1,052,193 | SEC↗ |
| AQST Aquestive Therapeutics, In | M Exercise deriv | 2019-11-30 | 2019-12-02 | 14,572 | — | $0 | 29,144 | SEC↗ |
| AQST Aquestive Therapeutics, In | F Tax w/h | 2019-11-30 | 2019-12-02 | 14,572 | $7.79 | $113.5K | 1,044,165 | SEC↗ |
| AQST Aquestive Therapeutics, In | M Exercise | 2019-11-30 | 2019-12-02 | 14,572 | — | $0 | 1,058,737 | SEC↗ |
| AQST Aquestive Therapeutics, In | M Exercise deriv | 2019-09-30 | 2019-10-02 | 329 | — | $0 | 991 | SEC↗ |
| AQST Aquestive Therapeutics, In | F Tax w/h | 2019-09-30 | 2019-10-02 | 145 | $3.18 | $461 | 1,044,165 | SEC↗ |
| AQST Aquestive Therapeutics, In | M Exercise | 2019-09-30 | 2019-10-02 | 329 | — | $0 | 1,044,310 | SEC↗ |
| AQST Aquestive Therapeutics, In | M Exercise deriv | 2019-08-31 | 2019-09-03 | 14,572 | — | $0 | 43,716 | SEC↗ |
| AQST Aquestive Therapeutics, In | M Exercise | 2019-08-31 | 2019-09-03 | 14,572 | — | $0 | 1,050,441 | SEC↗ |
| AQST Aquestive Therapeutics, In | F Tax w/h | 2019-08-31 | 2019-09-03 | 6,460 | $3.80 | $24.5K | 1,043,981 | SEC↗ |
| AQST Aquestive Therapeutics, In | M Exercise deriv | 2019-06-30 | 2019-07-02 | 329 | — | $0 | 1,320 | SEC↗ |
| AQST Aquestive Therapeutics, In | M Exercise | 2019-06-30 | 2019-07-02 | 329 | — | $0 | 1,036,018 | SEC↗ |
| AQST Aquestive Therapeutics, In | F Tax w/h | 2019-06-30 | 2019-07-02 | 149 | $4.20 | $626 | 1,035,869 | SEC↗ |
| AQST Aquestive Therapeutics, In | M Exercise deriv | 2019-05-31 | 2019-06-03 | 14,572 | — | $0 | 58,288 | SEC↗ |
| AQST Aquestive Therapeutics, In | F Tax w/h | 2019-05-31 | 2019-06-03 | 6,591 | $3.72 | $24.5K | 1,035,689 | SEC↗ |
| AQST Aquestive Therapeutics, In | M Exercise | 2019-05-31 | 2019-06-03 | 14,572 | — | $0 | 1,042,280 | SEC↗ |
| AQST Aquestive Therapeutics, In | M Exercise deriv | 2019-03-31 | 2019-04-01 | 329 | — | $0 | 1,649 | SEC↗ |
| AQST Aquestive Therapeutics, In | F Tax w/h | 2019-03-31 | 2019-04-01 | 263 | $6.91 | $1.8K | 1,027,708 | SEC↗ |
| AQST Aquestive Therapeutics, In | M Exercise | 2019-03-31 | 2019-04-01 | 329 | — | $0 | 1,027,971 | SEC↗ |
| AQST Aquestive Therapeutics, In | M Exercise deriv | 2019-02-28 | 2019-03-01 | 14,572 | — | $0 | 72,860 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2019-02-28 | 2019-03-04 | 75,000 | — | $0 | 75,000 | SEC↗ |
| AQST Aquestive Therapeutics, In | M Exercise | 2019-02-28 | 2019-03-01 | 14,572 | — | $0 | 1,034,363 | SEC↗ |
| AQST Aquestive Therapeutics, In | F Tax w/h | 2019-02-28 | 2019-03-01 | 6,721 | $8.05 | $54.1K | 1,027,642 | SEC↗ |
| AQST Aquestive Therapeutics, In | M Exercise deriv | 2018-12-31 | 2019-01-03 | 329 | — | $0 | 1,978 | SEC↗ |
| AQST Aquestive Therapeutics, In | M Exercise | 2018-12-31 | 2019-01-03 | 329 | — | $0 | 1,019,953 | SEC↗ |
| AQST Aquestive Therapeutics, In | F Tax w/h | 2018-12-31 | 2019-01-03 | 162 | $6.30 | $1.0K | 1,019,791 | SEC↗ |
| AQST Aquestive Therapeutics, In | P Buy | 2018-12-10 | 2018-12-11 | 1,000 | $7.78 | $7.8K | 1,019,624 | SEC↗ |
| AQST Aquestive Therapeutics, In | P Buy | 2018-12-06 | 2018-12-10 | 2,000 | $8.69 | $17.4K | 1,018,624 | SEC↗ |
| AQST Aquestive Therapeutics, In | M Exercise deriv | 2018-11-30 | 2018-12-04 | 14,572 | — | $0 | 87,432 | SEC↗ |
| AQST Aquestive Therapeutics, In | M Exercise | 2018-11-30 | 2018-12-04 | 14,572 | — | $0 | 1,023,801 | SEC↗ |
| AQST Aquestive Therapeutics, In | F Tax w/h | 2018-11-30 | 2018-12-04 | 7,177 | $8.59 | $61.7K | 1,016,624 | SEC↗ |
| AQST Aquestive Therapeutics, In | P Buy | 2018-11-21 | 2018-11-26 | 1,000 | $10.25 | $10.3K | 1,009,229 | SEC↗ |
| AQST Aquestive Therapeutics, In | M Exercise deriv | 2018-09-30 | 2018-10-02 | 329 | — | $0 | 2,307 | SEC↗ |
| AQST Aquestive Therapeutics, In | F Tax w/h | 2018-09-30 | 2018-10-02 | 162 | $17.51 | $2.8K | 1,008,229 | SEC↗ |
| AQST Aquestive Therapeutics, In | M Exercise | 2018-09-30 | 2018-10-02 | 329 | — | $0 | 1,008,391 | SEC↗ |
| AQST Aquestive Therapeutics, In | M Exercise deriv | 2018-08-31 | 2018-09-05 | 14,572 | — | $0 | 102,004 | SEC↗ |
| AQST Aquestive Therapeutics, In | M Exercise | 2018-08-31 | 2018-09-05 | 14,572 | — | $0 | 1,014,572 | SEC↗ |
| AQST Aquestive Therapeutics, In | F Tax w/h | 2018-08-31 | 2018-09-05 | 6,510 | $18.01 | $117.2K | 1,008,062 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2018-08-15 | 2018-08-17 | 2,636 | — | $0 | 2,636 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2018-08-15 | 2018-08-17 | 28,043 | — | $0 | 28,043 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2018-07-24 | 2018-07-26 | 240,165 | — | $0 | 240,165 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2018-07-24 | 2018-07-26 | 116,576 | — | $0 | 116,576 | SEC↗ |